（文章来源：证券日报） 证券日报网讯 8月27日晚间，荣泰健康发布公告称，公司第四届董事会第二十二次会议审议通过了《关 于公司2025年半年度报告及报告摘要的议案》等多项议案。 ...

证券日报网讯 8月27日晚间，荣泰健康发布公告称，公司第四届监事会第十七次会议审议通过了《关于 公司2025年半年度报告及报告摘要的议案》《关于公司2025年半年度募集资金存放与实际使用情况的专 项报告的议案》。 （文章来源：证券日报） ...

Group 1 - The core point of the article highlights that Rongtai Health's shareholder count decreased significantly by 33.34% from March 31, 2025, to June 30, 2025, totaling 13,384 households [1][2] - The average number of shares held per household increased from 8,835 shares to 13,300 shares, with an average market value of 361,300 yuan per household [1][2] - Compared to the average in the home appliance industry, Rongtai Health's shareholder count is below the industry average of 30,400 households, while its average market value per household is higher than the industry average of 147,400 yuan [1][2] Group 2 - From March 31, 2025, to June 30, 2025, Rongtai Health's stock price increased by 1.83%, despite the significant reduction in shareholder count [1][2] - During this period, the net inflow of main funds was 93.11 million yuan, while retail funds saw a net inflow of 13.28 million yuan, indicating mixed investor sentiment [2] - The stock appeared on the trading leaderboard four times during this period, with institutional special seats appearing twice [2]

| 代码 | | | 名称 │主力净流入（元）│主力净占比│游资净流入（元）│游资净占比│散户净流入（元）│散户净占比 | | | | | --- | --- | --- | --- | --- | --- | --- | | 603579 荣泰健康 | 2362.69万 | 4.27% | 2572.94万 | 4.65% | -4935.63万 | -8.91% | | 300247 融捷健康 | 48.10万 | 0.34% | 221.95万 | 1.55% | -270.05万 | -1.89% | | 002614 | -763.78万 | -9.96% | 250.36万 | 3.27% | 513.42万 | 6.70% | 以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。 从资金流向上来看，当日其他家电板块主力资金净流入1647.01万元，游资资金净流入3045.24万元，散户 资金净流出4692.26万元。其他家电板块个股资金流向见下表： 证券之星消息，8月27日其他家电板块较上一交易日下跌2.9%，融捷健康领跌。当 ...

Core Viewpoint - Rongtai Health (603579.SH) reported a decline in both revenue and net profit for the first half of 2025, indicating potential challenges in its financial performance [1] Financial Performance - The company achieved an operating revenue of 810 million yuan, representing a year-on-year decrease of 1.78% [1] - The net profit attributable to shareholders was 85.34 million yuan, down 23.35% year-on-year [1] - The net profit after deducting non-recurring gains and losses was 55.95 million yuan, reflecting a significant decline of 44.74% year-on-year [1] - Basic earnings per share stood at 0.49 yuan [1]

Group 1 - The board meeting of Shanghai Rongtai Health Technology Co., Ltd. was held on August 27, 2025, with all 9 directors present, ensuring compliance with legal and regulatory requirements [1][2] - The board unanimously approved the special report on the use of raised funds for the first half of 2025, with 100% approval from the directors [2]

Group 1 - The meeting of the fourth supervisory board of Shanghai Rongtai Health Technology Co., Ltd. was held on August 27, 2025, with all three supervisors present, confirming the legality and validity of the meeting [1] - The supervisory board approved the company's 2025 semi-annual report and the special report on the use of raised funds, with unanimous support from all non-related supervisors [1][1][1] Group 2 - The meeting was chaired by Mr. Cao Tao, and the notice and materials were distributed on August 15, 2025, through various methods [1] - The resolutions passed during the meeting included the approval of the semi-annual report and the report on the use of funds, both receiving 100% approval from the supervisors [1][1][1]

智通财经APP讯，荣泰健康(603579.SH)发布2025年半年度报告，该公司营业收入为8.1亿元，同比减少 1.78%。归属于上市公司股东的净利润为8533.69万元，同比减少23.35%。归属于上市公司股东的扣除非 经常性损益的净利润为5594.98万元，同比减少44.74%。基本每股收益为0.49元。 ...

| 证券代码：603579 | 证券简称：荣泰健康 | 公告编号：2025-057 | | --- | --- | --- | | 转债代码：113606 | 转债简称：荣泰转债 | | 上海荣泰健康科技股份有限公司 关于召开 2025 年半年度业绩说明会的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 会议召开时间：2025 年 09 月 04 日(星期四) 上午 11:00-12:00 会 议 召 开 地 点 ： 上 海 证 券 交 易 所 上 证 路 演 中 心 （ 网 址 ： http://roadshow.sseinfo.com/） 会议召开方式：上证路演中心网络文字互动 投资者可于 2025 年 08 月 28 日（星期四）至 09 月 03 日（星期三）16:00 前登录上证路演中心网站首页点击"提问预征集"栏目或通过公司邮箱 Public@rotai.com 进行提问。公司将在说明会上对投资者普遍关注的问题进 行回答。 上海荣泰健康科技股份有限公司（以下简称"公司"）于 2025 年 8 ...

经中国证券监督管理委员会《关于核准上海荣泰健康科技股份有限公司公开 发行可转换公司债券的批复》（证监许可[2020]2139 号）核准，并经上海证券交易 所同意，公司公开发行 600 万张 A 股可转换公司债券（每张面值 100 元），募集资 金总额为人民币 60,000.00 万元，扣除各项发行费用 601.77 万元（含税），实际募 集资金净额为人民币 59,398.23 万元。上述募集资金已于 2020 年 11 月 5 日全部到 位，并经中汇会计师事务所（特殊普通合伙）出具中汇会验[2020]6483 号验资报 告验证。 （二）本年度使用金额及当前余额 公司 2020 年未使用募集资金，2021 年使用募集资金 4,230.14 万元，2022 年 年使用募集资金 1,085.14 万元，2023 年使用募集资金 1,635.17 万元，2024 年使 用募集资金 4,971.69 万元，2025 年上半年使用募集资金 1,929.43 万元，截至 2025 年 6 月 30 日，结余募集资金余额为 52,729.66 万元（含利息收入扣除银行手续费 的净额 80.81 万元,理财产品投资收益 558 ...